tm logo
ALPHATAC
Live/Pending
WITHDRAWN BEFORE PUBLICATION

on 19 Dec 2024

Last Applicant/ Owned by

Suzanne Tassierstraat 1

Gent

BE

9052

Serial Number

97701222 filed on 02th Dec 2022

Registration Number

N/A

Correspondent Address

Clifford D. Hyra

Clifford D. Hyra FRESH IP PLC

RESTON, VA 20190

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ALPHATAC

Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, and veterinary science; Natural science services, namely, scientific research; Scientific research, namely, medical, bacteriological, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, and veterinary science; Natural science services, namely, scientific research; Scientific research, namely, medical, bacteriological, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratory services; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services; all of the aforesaid services not relating to means for pest control, fungicides, germicides and herbicide, and not relating to means for diagnostics


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances, namely, biotherapeutics for targeted protein degradation in cancer, immunological disease, and autoimmunological disease; Medical preparations and substances, namely, liquid, solid, and lyophilized protein-based preparations for medical uses and treatments for cancer, immunological disease, and autoimmunological disease; Medical and veterinary preparations and substances in the nature of liquid, solid, and lyophilized protein-based biotherapeutic preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations in the nature of medication for use in the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, pharmaceutical preparations for the treatment of disease, namely, cancer, immunological disorders, and autoimmunological disorders in humans and animals; bioculture preparations for pharmaceutical, medical, and veterinary purposes, namely, cultures of microorganisms for medical or veterinary use; Preparations and substances for use in drug discovery, namely, clinical medical reagents; all of the aforesaid goods excluding means for pest control, fungicides, germicides and herbicides and excluding means for diagnostics


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97701222

Mark Type

No Service Mark

Attorney Docket Number

No HDCPA-T466US

44D Filed

Yes

44D Current

Yes

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Dec 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
13th Dec 2024APPROVED FOR PUB - PRINCIPAL REGISTER
30th Aug 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
30th Aug 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
30th Aug 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
30th Aug 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
30th Aug 2024TEAS/EMAIL CORRESPONDENCE ENTERED
31st May 2024FINAL REFUSAL WRITTEN
31st May 2024FINAL REFUSAL E-MAILED
31st May 2024NOTIFICATION OF FINAL REFUSAL EMAILED